bpc-157 fda warning not approved peptide safety 2025 september The Hidden Risks of BPC‑157: What Patients Need FDA takes coser look at

It includes 1-5 intramuscular or subcutaneous injections of 1000 mcg crystalline cyanocobalamin daily, followed by oral doses of 1000-2000 mcg/day Parenteral administration should be reserved for those with significant neurological symptoms NICE guideline: Vitamin B 12 deficiency in over 16s: diagnosis and management: Malabsorption as the confirmed or suspected cause of vitamin B 12 deficiency: Offer replacement to people if: lifelong intramuscular vitamin B12 Autoimmune gastritis is the cause They have had a total gastrectomy They have had a complete terminal ileal resection If the person has a vitamin B 12 deficiency because of malabsorption that is not caused by autoimmune gastritis, or a total gastrectomy or complete terminal ileal resection (for example, malabsorption caused by coeliac disease, partial gastrectomy or some forms of bariatric surgery): Offer vitamin B 12 replacement and Consider intramuscular instead of

This blog post explores pernicious anemia as an inherited condition that strongly affects your health

Its a well-tolerated, low-risk option that provides fast, noticeable benefits

People and most animals have B12-producing bacteria living in their intestines

Overextending the cycle More than 8 weeks is not recommended without medical supervision

NNMT is active in fat tissue and has been associated in medical literature with metabolic changes seen in obesity and insulin resistance